1,284 Analyzed Papers
42,910 FDA Side-Effect Signals
148 Active Global Trials
— Trials Recruiting Now

Annual Research & Trial Trends

Sample

Research Share by MoA Target

Sample

Live Drug Repurposing Candidates

How FollicleIQ Works (3-Step Guide)

Accelerate your hair science R&D in three simple steps—from query to corporate B2B export.

01

Search Targets & Molecules

Enter any target protein, gene symbol (e.g. AR, SRD5A2), or chemical molecule name (e.g. Minoxidil, Finasteride) into our AI engine.

02

Synthesize NIH & FDA Metrics

Review real-time aggregated signal metrics: PubMed clinical literature count, OpenFDA FAERS adverse effect ratios, and ClinicalTrials.gov progress.

03

Export B2B PDF & Excel Reports

Instantly generate and download fully cited, audit-ready PDF briefs and Excel (.xlsx) spreadsheets for corporate executive and lab presentations.

Frequently Asked Questions (FAQ)

Everything you need to know about FollicleIQ data sources, subscriptions, and security.

Where does FollicleIQ source its biomedical data?

FollicleIQ directly queries official public REST APIs provided by the U.S. National Institutes of Health (NIH PubMed), U.S. Food & Drug Administration (OpenFDA FAERS), ClinicalTrials.gov, EMBL-EBI ChEMBL, UniProt, and AlphaFold Protein Structure Database. All analytical metrics include verifiable direct PMID and NCT reference links.

What does it cost?

Nothing. FollicleIQ is free and open access. There is no paid tier, no checkout, and no payment is collected. Earlier versions of this page advertised $49 and $299 monthly plans; those are withdrawn.

Are there alerts or email notifications?

No. The alert feature is not built. Nothing is monitored in the background and no email or Slack message is ever sent. The Alerts tab is left in place so this is stated where people look for it, not hidden.

Can I export reports for corporate presentations?

Yes, and it is free like everything else. You can export formatted PDF summaries and raw Excel (.xlsx) tables of the live results for pitch decks, grant proposals, and internal R&D briefs.

PubMed & BioRxiv Hair Loss Fact Analysis

AI collects research papers and provides 3-line fact summaries, targets, and key molecules.

FDA Adverse Event (FAERS) & Signal Analysis

Tracks hypertrichosis (hair growth) side-effect signals for drug repurposing.

Top Hypertrichosis Report Drugs (Repurposing Candidates)

Generic Name Original Indication Hypertrichosis Cases Repurposing Potential Fact Analysis

FDA Side-Effect Signal Comparison

Global Clinical Trials Pipeline

Tracking 148 active global clinical trials on Alopecia (ClinicalTrials.gov).

NCT ID Trial Title Sponsor / Pharma Phase Target / Therapy Status

Target Protein & Compound 3D Explorer

Integrated public facts from ChEMBL, UniProt, and AlphaFold 3D structure predictions.

AlphaFold & ChEMBL 3D Protein-Molecule Simulation

Loading structure…

Loading…

Mean pLDDT (model confidence) —
ChEMBL target —
Very high >90 Confident 70–90 Low 50–70 Very low <50
AR (Androgen Receptor)
Inhibitor Required
Androgen Receptor (5α-reductase Follicular Atrophy)
💡 Biological Fact: Binds DHT to induce TGF-β1 in dermal papilla cells. Inhibition extends follicle lifespan.
Skin Permeability (LogP): 3.2 (Excellent Absorption, 372Da)
Patent Freedom (FTO): Patent Expired (Free FTO)
IC50 Potency: Finasteride (12.4 nM) / Dutasteride (0.5 nM)
GSK-3β / Wnt Path
Activator Required
Glycogen Synthase Kinase 3β (Stem Cell Regen)
💡 Biological Fact: Blocking GSK-3β accumulates β-catenin to trigger Telogen to Anagen transition.
Skin Permeability (LogP): 2.8 (Topical Formulation Fits)
Patent Freedom (FTO): New Use Patent Filing Area
IC50 Potency: Valproate Deriv (8.2 nM) / CHIR-99021 (9.8 nM)
CRTH2 (PTGDR2)
Inhibitor Required
Prostaglandin D2 Receptor 2 (Inflammatory Atrophy)
💡 Biological Fact: PGD2 is 3x higher in balding scalp. Blocking CRTH2 prevents follicle miniaturization.
Skin Permeability (LogP): 3.9 (Lipophilic Scalp Lotion Fit)
Patent Freedom (FTO): Repurposing Opportunity Available
IC50 Potency: Ramatroban (24.1 nM) / Setipiprant (67.0 nM)

Fact Alerts — not available

This feature is not built. Nothing is monitored in the background and no notification is ever sent. The form below is kept so this is stated where people look for it.

Register New Fact Alert Keyword

Active Subscription Alert Feeds

Keyword Target DB Channel Latest Captured Fact Status
Wnt/β-catenin PubMed, ClinicalTrials Email (Daily) PMID: 38912041 New Paper Captured Active Monitoring
JAK3 Inhibitor OpenFDA, ClinicalTrials Slack Webhook Pfizer Phase 3 Status Updated Active Monitoring

Free and open access

Every feature below is available to everyone at no cost. There is no paid tier and no checkout.

Everything, free

$0

Live search across PubMed, openFDA FAERS, ClinicalTrials.gov, ChEMBL and AlphaFold

  • Cross-source search with direct PMID / NCT links
  • openFDA adverse-event signals and repurposing view
  • AlphaFold 3D structure explorer
  • PDF and Excel export of live results

What is not available

  • Alerts and notifications are not built. Nothing is monitored and no email or Slack message is ever sent.
  • There is no paid plan and no payment is collected. Any pricing you may have seen previously is withdrawn.
  • Editorial lists such as the repurposing candidates are our own judgement. The counts beside them are live query results; the selection is not.

Automated B2B Fact Report Generator

Generate verified fact briefing reports based on public database evidence for cosmetic R&D and labs.

Custom B2B Report Settings

Report Live Preview (Fact Summary Sample)